March 8, 2013 / 10:41 AM / in 4 years

BRIEF-Takeda submits marketing authorisation application for vedolizumab in European union

1 Min Read

LONDON, March 8 (Reuters) - Takeda Pharmaceutical Co Ltd : * Submits marketing authorisation application for vedolizumab in moderately to

severely active ulcerative colitis and crohn's disease in the European union

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below